1,367
Participants
Start Date
December 18, 2018
Primary Completion Date
August 26, 2024
Study Completion Date
May 29, 2026
Pembrolizumab
IV infusion
Placebo for pembrolizumab
IV infusion
Carboplatin
IV infusion
Paclitaxel
IV infusion
Olaparib
Oral tablet
Placebo for olaparib
Oral tablet
Bevacizumab
IV infusion
Docetaxel
IV infusion
Linkou Chang Gung Memorial Hospital ( Site 2501), Taoyuan District
National Cheng Kung University Hospital ( Site 2508), Tainan City
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz ( Site 0802), Miskolc
Orszagos Onkologiai Intezet ( Site 0800), Budapest
Uzsoki Utcai Korhaz ( Site 0803), Budapest
Cliniques Universitaires Saint-Luc ( Site 0312), Brussels
Imelda Ziekenhuis Bonheiden ( Site 0301), Bonheiden
Wits Clinical Research ( Site 1702), Johannesburg
Sandton Oncology Medical Group PTY LTD ( Site 1712), Sandton
St George Hospital ( Site 2207), Kogarah
UZ Leuven Campus Gasthuisberg ( Site 0306), Leuven
Sunshine Hospital. ( Site 2205), St Albans
Monash Health ( Site 2204), Clayton
Ballarat Health Services ( Site 2202), Ballarat
Jessa Ziekenhuis ( Site 0309), Hasselt
CHU de Liege ( Site 0310), Liège
Debreceni Egyetem Klinikai Kozpont ( Site 0801), Debrecen
The Oncology Centre ( Site 1709), Durban
Cairns and Hinterland Hospital and Health Service ( Site 2201), Cairns
Grand Hopital de Charleroi ( Site 0302), Charleroi
Cancer Care Langenhoven Drive Oncology Centre ( Site 1701), Port Elizabeth
Outeniqua Cancercare Oncology Unit ( Site 1708), George
Centre Hospitalier de l'Ardenne ( Site 0303), Libramont
Cape Town Oncology Trials Pty Ltd ( Site 1707), Kraaifontein
Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 0805), Pécs
Cancercare ( Site 1706), Cape Town
Groote Schuur Hospital ( Site 1704), Cape Town
AZ Maria Middelares Gent ( Site 0300), Ghent
UZ Gent ( Site 0307), Ghent
National Taiwan University Hospital ( Site 2502), Taipei
Hospital Provincial San Pedro de Alcantara ( Site 1607), Cáceres
A.O.U. Citta della Salute e della Scienza di Torino ( Site 1104), Turin
MacKay Memorial Hospital ( Site 2500), Taipei
Northwell Health- Monter Cancer Center ( Site 0075), Lake Success
Taipei Veterans General Hospital ( Site 2503), Taipei
Hopital de la Timone ( Site 0617), Marseille
Charite Campus Virchow-Klinikum - CVK ( Site 0700), Berlin
Seoul National University Bundang Hospital ( Site 2404), Seongnam-si
Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 1608), A Coruña
Uludag Universitesi Tip Fakultesi ( Site 1904), Bursa
Hospital Universitario de Donostia ( Site 1602), Donostia / San Sebastian
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1115), Milan
Istituto Europeo di Oncologia ( Site 1100), Milan
Virginia Cancer Specialists, PC ( Site 8003), Gainesville
Weinberg Cancer Institute at Franklin Square ( Site 0035), Baltimore
ASST Lecco. Ospedale A. Manzoni ( Site 1101), Lecco
Staedtisches Krankenhaus Kiel GmbH ( Site 0709), Kiel
Hospital Universitario Lucus Augusti ( Site 1609), Lugo
Clinica Universitaria de Navarra ( Site 1600), Madrid
Municipal non-profit Enterprise Khmelnytskyi Regional Antitu-Gynecological Oncology department, Poli, Khmelnytskyi
CHU de Brest -Site Hopital Morvan ( Site 0616), Brest
Institut de Cancerologie du Gard - CHU Caremeau ( Site 0610), Nîmes
Emory School of Medicine ( Site 0053), Atlanta
Northeast Georgia Medical Center ( Site 0029), Gainesville
Memorial Health University Medical Center ( Site 0011), Savannah
A.O. Univ. S. M. della Misericordia ( Site 1114), Udine
Istanbul Universitesi Istanbul Tip Fakultesi ( Site 1900), Istanbul
Bakirkoy Sadi Konuk Egitim ve Arastirma Hastanesi ( Site 1907), Istanbul
Medipol Universite Hastanesi ( Site 1909), Istanbul
Sarasota Memorial Hospital ( Site 0023), Sarasota
Istanbul Acibadem University Atakent Hospital ( Site 1902), Küçükçekmece
Istituto Oncologico Veneto IRCCS ( Site 1113), Padua
University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham
Presidio Ospedaliero Santa Chiara ( Site 1109), Trento
Saint Dominic - Jackson Memorial Hospital ( Site 0072), Jackson
RMI - Sumy Regional Clinical Oncology Dispensary ( Site 2191), Sumy
Universitaetsklinikum Duesseldorf ( Site 0704), Düsseldorf
China Medical University Hospital ( Site 2506), Taichung
University of Kentucky ( Site 0045), Lexington
Taichung Veterans General Hospital ( Site 2510), Taichung
Hospital Universitario Virgen del Rocio ( Site 1604), Seville
Institut de Cancerologie Lucien Neuwirth ( Site 0613), Saint-Priest-en-Jarez
OSU Wexner Medical Center ( Site 0076), Hilliard
The Bing Cancer Center ( Site 0044), Columbus
Klinikum Dortmund gGmbH ( Site 0717), Dortmund
Oncology/Hematology Care Clinical Trials, LLC ( Site 8001), Cincinnati
Miami Valley Hospital [Dayton, OH] ( Site 0073), Centerville
Instituto Valenciano de Oncologia ( Site 1601), Valencia
Hospital General Universitario de Valencia ( Site 1610), Valencia
Saint Vincent Hospital and Health Center ( Site 0012), Indianapolis
HELIOS Klinikum Krefeld ( Site 0715), Krefeld
Universitaetsklinikum Muenster ( Site 0720), Münster
Changhua Christian Hospital ( Site 2507), Changhua
Uniklinik RWTH Aachen ( Site 0718), Aachen
University of Iowa Hospital and Clinics ( Site 0005), Iowa City
Gynaekologisches Zentrum ( Site 0712), Bonn
MEDICAL COLLEGE OF WISCONSIN ( Site 0064), Milwaukee
Centre D Oncologie de Gentilly ( Site 0609), Nancy
Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 1906), Sakarya
Sanford Gynecology Oncology ( Site 0004), Sioux Falls
Sanford Roger Maris Cancer Center ( Site 0082), Fargo
Dr. Sudarshan K. Sharma, LTD ( Site 0061), Hinsdale
Rush University Medical Center ( Site 0019), Chicago
University of Chicago ( Site 0049), Chicago
Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2180), Kharkiv
Washington University - School of Medicine ( Site 0062), St Louis
MI Odessa Regional Oncological Centre ( Site 2121), Odesa
Caritas Klinikum Saarbruecken St. Theresia ( Site 0702), Saarbrücken
Centre Paul Strauss ( Site 0615), Strasbourg
Nebraska Methodist Hospital ( Site 0063), Omaha
Hopital Prive Jean Mermoz ( Site 0607), Lyon
IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 1108), Bari
Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0707), Stuttgart
Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0710), Munich
Hopital Tenon ( Site 0612), Paris
Texas Oncology-Dallas Presbyterian Hospital ( Site 8004), Dallas
Parkland Hospital ( Site 0081), Dallas
UT Southwestern Medical Center ( Site 0046), Dallas
Texas Oncology, P.A. Texas Oncology-Tyler ( Site 8006), Tyler
MI Precarpathian Clinical Oncology Center ( Site 2181), Ivano-Frankivsk
Texas Oncology, P.A. - Bedford ( Site 8005), Bedford
Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2170), Lviv
A.O.U. Federico II di Napoli ( Site 1107), Napoli
Sacro Cuore di Gesu Fatebenefratelli ( Site 1112), Benevento
University of Arizona Cancer Center ( Site 0074), Tucson
Central City Clinical Hospital ( Site 2150), Uzhhorod
Disney Family Cancer Center ( Site 0042), Burbank
Kaiser Permanente Oncology Clinical Trial - San Francisco ( Site 0078), San Francisco
Kaiser Permanente N. CA Regional Oncology Clinical Trials ( Site 0008), Vallejo
Kaiser Permanente Oncology Clinical Trial - Walnut Creek ( Site 0080), Walnut Creek
Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077), Oakland
Institut Gustave Roussy ( Site 0600), Villejuif
Kaiser Permanente Oncology Clinical Trial - Santa Clara ( Site 0079), Santa Clara
Ospedale Cannizzaro ( Site 1110), Catania
Kaiser Permanente Oncology Clinical Trials-Roseville ( Site 0084), Roseville
Kaiser Permanente Oncology Clinical Trials-Sacramento ( Site 0083), Sacramento
Instituto Nacional de Cancerologia E.S.E ( Site 2910), Bogotá
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 2912), Bogotá
FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1500), Moscow
FSCC of Special Types of Med. Care and Technologies ( Site 1503), Moscow
Medical Rehabilitation Center ( Site 1502), Moscow
Arkhangelsk Clinical Oncological Dispensary ( Site 1508), Arkhangelsk
National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1504), Saint Petersburg
City Clinical Oncology Center ( Site 1505), Saint Petersburg
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 2913), Valledupar
Oncomedica S.A. ( Site 2911), Montería
A. Tsyb Medical Radiological Research Center ( Site 1513), Obninsk
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509), Kazan'
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1507), Ufa
Centro Medico Imbanaco de Cali S.A ( Site 2909), Santiago de Cali
Hemato Oncologos S.A. ( Site 2906), Santiago de Cali
Centro Oncologico Antofagasta ( Site 2804), Antofagasta
Oncocentro ( Site 2801), Viña del Mar
Carmel Medical Center ( Site 1007), Haifa
Rambam Medical Center ( Site 1002), Haifa
Hillel Yaffe Medical Center ( Site 1011), Hadera
Centro Investigación del Cáncer James Lind ( Site 2810), Temuco
Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 2808), Temuco
Rabin Medical Center ( Site 1004), Petah Tikva
Chaim Sheba Medical Center ( Site 1000), Ramat Gan
Edith Wolfson Medical Center ( Site 1003), Holon
Sourasky Medical Center ( Site 1001), Tel Aviv
Fundacion Arturo Lopez Perez FALP ( Site 2800), Santiago
Sociedad Oncovida S.A. ( Site 2807), Santiago
Iram Cancer Research ( Site 2809), Santiago
Pontificia Universidad Catolica de Chile ( Site 2805), Santiago
Soroka Medical Center ( Site 1006), Beersheba
Shaare Zedek Medical Center ( Site 1005), Jerusalem
Smilow Cancer Center at Yale-New Haven ( Site 0057), New Haven
Dartmouth Hitchcock Medical Center ( Site 0024), Lebanon
MD Anderson Cancer Center at Cooper ( Site 0067), Camden
Holy Name Medical Center ( Site 0037), Teaneck
Women and Infants Hospital [Providence, RI] ( Site 0039), Providence
Instituto do Cancer do Ceara ( Site 2707), Fortaleza
Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 2708), Goiânia
Hospital Erasto Gaertner ( Site 2716), Curitiba
Hospital de Caridade de Ijui ( Site 2712), Ijuí
Hospital Bruno Born ( Site 2704), Lajeado
Hospital Nossa Senhora Da Conceicao ( Site 2703), Porto Alegre
Instituto Nacional de Cancer Hospital do Cancer II ( Site 2700), Rio de Janeiro
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 2714), São Paulo
Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 2706), São Paulo
Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 2710), São Paulo
Tom Baker Cancer Centre ( Site 0200), Calgary
Kingston Health Sciences Centre ( Site 0207), Kingston
The Credit Valley Hospital ( Site 0206), Mississauga
Princess Margaret Hospital.. ( Site 0202), Toronto
CIUSSS du Saguenay-Lac-St-Jean ( Site 0218), Chicoutimi
CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0219), Montreal
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0208), Montreal
Royal Victoria Hospital McGill University Health Centre ( Site 0211), Montreal
Biomelab S A S ( Site 2900), Barranquilla
Fakultni nemocnice Brno ( Site 0404), Brno
Fakultni nemocnice Ostrava ( Site 0403), Ostrava-Poruba
Vseobecna fakultni nemocnice v Praze ( Site 0400), Prague
Nemocnice Na Bulovce ( Site 0401), Prague
Fakultni nemocnice Olomouc ( Site 0402), Olomouc
Klinikum Chemnitz gGmbH ( Site 0711), Chemnitz
Azienda Ospedaliera Policlinico Umberto I ( Site 1111), Roma
Policlinico Universitario Gemelli ( Site 1105), Roma
National Cancer Center Hospital East ( Site 2602), Kashiwa
National Hospital Organization Shikoku Cancer Center ( Site 2601), Matsuyama
Ehime University Hospital ( Site 2600), Tōon
Gunma Prefectural Cancer Center ( Site 2609), Ōta
Hokkaido University Hospital ( Site 2607), Sapporo
Iwate Medical University Hospital ( Site 2606), Shiwa-gun
St. Marianna University School of Medicine Hospital ( Site 2613), Kawasaki
University of the Ryukyus Hospital ( Site 2616), Nakagami-gun
Saitama Medical University International Medical Center ( Site 2604), Hidaka
Saitama Cancer Center ( Site 2614), Kitaadachi-gun
National Defense Medical College Hospital ( Site 2608), Tokorozawa
Kyorin University Hospital ( Site 2610), Mitaka
Kagoshima City Hospital ( Site 2612), Kagoshima
Niigata Cancer Center Hospital ( Site 2618), Niigata
Osaka International Cancer Institute ( Site 2617), Osaka
National Cancer Center Hospital ( Site 2605), Tokyo
Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warsaw
Bialostockie Centrum Onkologii ( Site 1412), Bialystok
Szpitale Pomorskie Sp. z o.o. ( Site 1407), Gdynia
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1406), Gliwice
Swietokrzyskie Centrum Onkologii SPZOZ ( Site 1410), Kielce
Department of Medical Oncology ( Site 1703), Pretoria
Curo Oncology ( Site 1710), Pretoria
Wilgers Oncology Centre ( Site 1705), Pretoria
Little Company of Mary Hospital ( Site 1700), Pretoria
Seoul National University Hospital ( Site 2403), Seoul
Severance Hospital Yonsei University Health System ( Site 2400), Seoul
Asan Medical Center ( Site 2402), Seoul
Samsung Medical Center ( Site 2401), Seoul
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 1603), L'Hospitalet de Llobregat
Xarxa Assistencial Universitaria Manresa ( Site 1605), Manresa
Hospital de Terrassa ( Site 1606), Terrassa
Etlik Zubeyde Hanim Kadin Hastaliklari Egitim ve Arastirma Hastanesi ( Site 1903), Ankara
Ankara UTF Cebeci Arastırma ve Uygulama Hastanesi ( Site 1905), Ankara
Akdeniz Universitesi Tıp Fakultesi ( Site 1901), Antalya
Kyiv City Clinical Oncological Center ( Site 2140), Kyiv
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Gynecologic Oncology Group
NETWORK
Merck Sharp & Dohme LLC
INDUSTRY